Latest news with #GLM
Business Upturn
27-05-2025
- Business
- Business Upturn
Treatment.com AI Grants Stock Options and RSUs
By GlobeNewswire Published on May 28, 2025, 02:33 IST VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units ('RSUs') and 330,132 stock options ('Options') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact [email protected] . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: [email protected] Media inquiries: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hamilton Spectator
27-05-2025
- Business
- Hamilton Spectator
Treatment.com AI Grants Stock Options and RSUs
VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units ('RSUs') and 330,132 stock options ('Options') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Yahoo
27-05-2025
- Business
- Yahoo
Treatment.com AI Grants Stock Options and RSUs
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') announces that it has granted an additional 633,589 restricted share units ('RSUs') and 330,132 stock options ('Options') to continuing employees and consultants of Rocket Doctor Inc., the Company's wholly-owned subsidiary (see News Release dated April 10, 2025). The Options are each exercisable for one common share of the Company at an exercise price of C$0.50 per share for a period of three years from the grant date and vest over a one-year term. The RSUs are valid for a term of three years and vest over a period of one year from the grant date. All Options and RSUs are subject to the terms of the Company's equity plans and applicable securities law hold periods. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO Email: ehamza@ Media inquiries: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time of India
23-04-2025
- Business
- Time of India
Zhipu AI ramps up overseas expansion strategy ahead of IPO
China's Zhipu AI is ramping up its overseas expansion through a partnership with Alibaba Cloud , an executive said on Wednesday, as the startup prepares for an initial public offering. The Beijing-headquartered startup is pitching governments globally to help them launch localised sovereign AI agents, vice-president Carol Lin told an audience at tech conference GITEX Asia . The company now has offices in the Middle East, Singapore, the United Kingdom and Malaysia, and is running joint " innovation centers " across Asia, including in Indonesia and Vietnam, she said. Founded in 2019 as a Tsinghua University spinoff, Zhipu AI has emerged among China's front-runners in the artificial intelligence race, alongside AI-focused startups Moonshot AI, Minimax, and Baichuan, while also competing with tech giants such as ByteDance and Alibaba. It initiated preliminary steps toward an initial public offering this month, according to filings posted on the Chinese securities regulator's website, aiming to become the first of China's emerging AI companies to go public. The company secured three rounds of state-backed funding within weeks in March, including a 300 million yuan ($41.5 million) investment from the Chengdu municipal government. Live Events Zhipu was added to the U.S. Commerce Department's export control entity list in January, barring it from procuring U.S. components. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories An advertisement for Zhipu's GLM shown during the presentation depicted a foreigner arriving in Beijing and using the firm's AI agent to send a WhatsApp message and search on Google Maps and Reddit for Beijing recommendations.
Reuters
23-04-2025
- Business
- Reuters
Zhipu AI ramps up overseas expansion strategy ahead of IPO
SINGAPORE April 23 - China's Zhipu AI is ramping up its overseas expansion through a partnership with Alibaba Cloud, an executive said on Wednesday, as the startup prepares for an initial public offering. The Beijing-headquartered startup is pitching governments globally to help them launch localised sovereign AI agents, vice-president Carol Lin told an audience at tech conference GITEX Asia. The company now has offices in the Middle East, Singapore, the United Kingdom and Malaysia, and is running joint 'innovation centers' across Asia, including in Indonesia and Vietnam, she said. Founded in 2019 as a Tsinghua University spinoff, Zhipu AI has emerged among China's front-runners in the artificial intelligence race, alongside AI-focused startups Moonshot AI, Minimax, and Baichuan, while also competing with tech giants such as ByteDance and Alibaba ( opens new tab. It initiated preliminary steps toward an initial public offering this month, according to filings posted on the Chinese securities regulator's website, aiming to become the first of China's emerging AI companies to go public. The company secured three rounds of state-backed funding within weeks in March, including a 300 million yuan ($41.5 million) investment from the Chengdu municipal government. Zhipu was added to the U.S. Commerce Department's export control entity list in January, barring it from procuring U.S. components. An advertisement for Zhipu's GLM shown during the presentation depicted a foreigner arriving in Beijing and using the firm's AI agent to send a WhatsApp message and search on Google Maps and Reddit for Beijing recommendations.
